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(57)	 ABSTRACT
Method and system for processing of a liquid ("contaminant
liquid") containing water and containing urine and/or other
contaminants in a two step process. Urine, or a contaminated
liquid similar to and/or containing urine and thus having a
relatively high salt and urea content is passed through an
activated carbon filter to provide a resulting liquid, to remove
most of the organic molecules. The resulting liquid is passed
through a semipermeable membrane from a membrane first
side to a membrane second side, where a fortified drink hav-
ing a lower water concentration (higher osmotic potential)
than the resulting liquid is positioned. Osmotic pressure dif-
ferential causes the water, but not most of the remaining
inorganic (salts) contaminant(s) to pass through the mem-
brane to the fortified drink. Optionally, the resulting liquid is
allowed to precipitate additional organic molecules before
passage through the membrane.
8 Claims, 4 Drawing Sheets
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CONTAMINATED WATER TREATMENT
FIELD OF THE INVENTION
This invention relates to processing and recycling of liquid,
including urine, to remove contaminants in the liquid.
BACKGROUND OF THE INVENTION
The Crew Exploration Vehicle ("CEV") and the Lunar
Surface Access Module ("LSAM"), to be used for space
exploration, will require new life support systems to support
the crew on journeys lasting from a few days to several weeks,
or longer. These life support systems should also be designed
to reduce the mass required to keep humans alive in space.
Water accounts for about 80 percent of the daily mass intake
required to keep a person alive. As a result, recycling water
offers a high return on investment for space life support.
Water recycling can also increase mission safety by providing
an emergency supply of drinking water, where another supply
is exhausted or contaminated. For a three-day CEV mission to
the International Space Station (ISS), water recycling can
reduce the mass required to be transported to provide drinking
water by 65 percent, when compared to stored water. For an
18-day Lunar mission, a mass savings of about 70 percent is
possible. These technologies also increase safety by provid-
ing a lightweight back-up to stored supplies, and they allow
astronauts to meet daily drinking water requirements by recy-
cling the water contained in their own urine. During a three-
day CEV emergency return to Earth, this capability could be
critical to the crews' survival. These technologies also con-
vert urine into a concentrated brine that is biologically stable
and non-threatening and can be safely stored onboard. This
approach eliminates the need to have a dedicated vent to
dump urine overboard. This would result in one less through
hull fitting on the CEV spacecraft (a significant safety advan-
tage).
What is needed is a system for recycling urine (1) to pro-
vide a renewable source of drinking water, (2) to reduce the
mass of water initially stored aboard a spacecraft, (3) to
provide a temporary source of additional nutrients for use by
a spacecraft occupant, (4) to reduce the volume of, and pro-
vide a biologically safe form of, urine residuals (i.e. waste or
non-water residues from urine) temporarily stored aboard a
spacecraft and (5) reduce or eliminate the need for urine
dumping during a space voyage.
SUMMARY OF THE INVENTION
These needs are met by a system and associated method
that provides a contaminant treatment pouch, referred to as a
"urine cell" or "contaminant cell," that converts urine or
another liquid containing contaminants into a fortified drink,
engineered to meet human hydration, electrolyte and caloric
requirements, using a variant of forward osmosis ("FO") to
draw water from a urine container into the concentrated for-
tified drink as part of a recycling stage. An activated carbon
pre-treatment removes most organic molecules. Salinity of
the initial liquid mix (urine plus other) is synergistically used
to enhance the precipitation organic molecules so that acti-
vated carbon can remove most of the organics. A functional
osmotic bag is then used to remove inorganic contaminants. If
a contaminant is processed for which the saline content is
different than optimal for precipitating organic molecules, the
saline content of the liquid should be adjusted toward the
optimal value for that contaminant.
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The development of a water recycling systems to support
CEV and LSAM missions can significantly reduce the mass
of life support mechanisms. Current plans for the CEV
assume that water is "tanked" and that urine is vented over-
5 board. This open loop approach does not attempt to minimize
launch mass, and it requires provisions of at least one addi-
tional through-wall penetrations. The CEV is, by definition a
pressure vessel upon which the crew's life depends and thus
any through wall fitting represents a potentially fatal (to the
io crew) failure point in vehicle design. The CEV, Block 1
mission, which is to transfer crew and limited cargo to ISS,
and Block 2, a Lunar mission, are both relatively short flight
duration vehicles, at most a few weeks. Short duration mis-
sions can be addressed by the use of consumable water treat-
15 ment products. These products offer reduced mass and pro-
duce recycled water for only a fraction of the weight of the
water itself. For example, a disposable water purification
system, such as the urine cell, could produce 1 Kg of drinking
water from urine with only 300 gm of water purification
20 equipment, a 70 percent reduction in mass below what is
required with stored water.
BRIEF DESCRIPTION OF THE DRAWINGS
25	 FIG. 1 schematically illustrates the location of the basic
X-Pack configuration (prior Art).
FIG. 2 illustrates an embodiment of the invention.
FIGS. 3A and 3B show a flow chart of a procedure for
practicing the invention.
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DESCRIPTION OF BEST MODE OF THE
INVENTION
An FO based urine cell 11 utilizing both activated carbon
35 (AC) and the X-PackTM technology, disclosed by Hydeation
Technologies, Inc., is illustrated in FIG. 1. See, for example
U.S. Pat. No. 6,849,184, issued to Lampi et al for previous
disclosure of FO membrane cell 15. In the invention a bladder
pump 13 is fed by a urine collector 12 and moves the liquid
40 through an activated carbon (AC) filter 14 into a membrane
container in a pouch 15. The membrane promotes separation
of water from urine, and the product, having a lowered urea
content, is drawn off as product.
The invention 21, illustrated in FIG. 2, is an improvement
45 of technologies similar to the X-PackTM device. The liquid to
be treated is passed through an activated carbon filter 24
(granules or porous block or another suitable filter mecha-
nism), which absorbs a majority of the remaining organic
molecules to provide a resulting liquid. The resulting liquid is
5o received by a container 25 that is positioned adjacent to a first
side of a semipermeable, preferably hydrophilic, membrane
26 (e.g., cellulous triacetate) that allows water diffuse through
it, but blocks most contaminants (urea, brine, etc.) due to a
micro-porous construction of the filter. A container 27 of a
55 concentrated fortified drink 28 is positioned adjacent to a
second side of the membrane 26. Some precipitation of the
remaining organic molecules occurs within the container 25.
Water is drawn through the membrane 26, from the first
side to the second side, by an osmotic potential differential
6o AOP, generated by the feed (urine or another contaminated
liquid) and by sugars and electrolytes contained in the forti-
fied drink 28 that is concentrated (strength range 2-20 times
normal strength, or more if desired). Water diffuses across the
membrane 26 from the urine (water-rich) first side to the
65 concentrated fortified drink (water-poor) second side in order
to (partly) equalize the osmotic potential. During this diffu-
sion process, the concentrated fortified drink 28 will become
US 7,655,145 B1
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diluted through uptake of water, and the urine will become
more concentrated by loss of water. The fortified drink con-
centrate has the sugars, electrolytes and calories needed by a
human and is formulated so that the final product is diluted to
a level appropriate for human consumption. Because the pro-
cess uses osmotic potential OP rather than hydraulic pressure,
the process is referred to as forward osmosis ("FO"), which
can be thought of as running reverse osmosis ("RO") in
reverse. Because the process uses osmotic potential instead of
hydraulic pressure, it has been shown to have fewer mem-
brane fouling problems that are inherent to RO and micro-
filtration.
Table 1 presents data on the treatment of organic com-
pounds using the membranes and AC filter selected for use in
the urine cell (more generally, contaminant cell). Table 2
provides the results of bacteriological and viral rejection tests
of the X-PackTM membranes.
TABLE 1
Proiected Performance of the Urine Cell
Stage of Treatment Typical Values (in mg/L TOC)
Raw Urine 2,500 to 5,500 mg/L
After GAC Treatment 50 to 100 mg/L
After CTA (stock) Forward 20 to 30 mg/L
Osmosis Membrane
Theoretical System 1 to 2 mg/L
Performance Limit with
Optimal Membranes
TABLE 2
Bacterial and Viral Testing
Test 1 hr 24 hr
Description sample sample
Anthrax Permeation
1.200,000/ml 0
Pigment Ink Dilution
0.4-1.0 micron 0 0
E. Coli Permeation
colony counts 1,000,000/ml 0 0
colony counts 100,000,000/ml 0 0
M 13 phage Permeation
phage counts 10,000,000/ml 0 0
phage counts 1,000,000,000/ml 0 0
MS2 phage Permeation
phage counts 1,000,000/ml 0 0
phage counts 100,000,000/ml 0 0
M13 phageDNA Permeation
2 mg in 4 liters 0 0
Although a technology, such as the basic X-PackTM device,
is capable of removing most inorganic compounds, this
device will not reliably remove small non-polar organics or
ammonia; up to 50 percent of these compounds will pass
through the membrane. Urine contains many of these types of
contaminates. Activated carbon, as granules or in a porous
block, is used to pre-treat the urine and to remove many, but
not all, organic molecules, including most non-polar organ-
ics. Activated carbon also has a weak affinity for ammonia.
The relatively high concentration of salts in urine in FIG. 2
works synergistically to improve the performance of the acti-
vated carbon. Commercially available AC is used.
Preferably, the system 21 provides for the collection 22 (12
in FIG. 1) and movement 23 (13 in FIG. 1) of the urine,
preceding to an activated carbon (`AC") porous filter 24. The
relatively high salinity of the urine enhances the performance
5 of the AC filter 24 by decreasing the solubility of organic
molecules in the input liquid, significantly increasing the
affinity of these molecules for AC, resulting in a product with
approximately 50 mg/liter total organic carbon (TOC)
remaining, as compared to about 200 mg/liter TOC (as urea),
10 after AC treatment of fresh water, with no urine salts present.
Preferably, the urine temperature and the fortified drink tem-
perature are in a range between room temperature and about
20 to 30° C.; and/or the pH of the fortified drink is adjusted to
be no higher than about 8.
15 FIG. 3 is a flow chart of a procedure for practicing the
invention. In step 31, a liquid containing at least one contami-
nant ("contaminant liquid"), usually urine or a substantially
similarly contaminated liquid, is received. In step 32, the
contaminant liquid is passed through an activated carbon
20 filter to produce a resulting liquid in which a majority of
organic molecules have been removed. In step 33 (optional),
a remainder of organic molecules in the resulting liquid are
allowed to precipitate from solution, before passage through
a membrane (step 34). In step 34, a semipermeable membrane
25 is provided, having a first side and a second side, and being
selected to allow passage therethrough of water in a direction
that tends to equalize concentration of water on the first and
second sides of the membrane. In step 35, the resulting liquid
is positioned in contact with at least a portion of the mem-
3o bran first side.
In step 36, a concentrated fortified drink, having a low
concentration of water compared to a concentration of water
in the resulting (from AC treatment) liquid, is positioned in
contact with at least a portion of the membrane second side. In
35 step 37, a portion of the resulting liquid is allowed to pass
through the membrane, from the first side to the second side
into the fortified drink, to reduce an imbalance of concentra-
tion of water on the first and second sides of the membrane. In
step 38, the fortified drink and the water that has passed
40 through the membrane are collected.
Tests performed on the urine cell indicate that: (1) raw
urine has a total organic content ("TOC") of 2,500-5,000
mg/liter, before treatment; (2) after treatment, TOC lies in a
range of 25-50 mg/liter; and (3) an optimal treatment accord-
45 ing to the invention can theoretically lower TOC to 1-2 mg/li-
ter. Urea is the source of the majority of TOC present in urine,
and testing indicates that as much as 95-97 percent of urea can
be removed using the invention.
The membranes used in the urine cell should be an effective
5o barrier to inorganic compounds. Cellulose tri-acetate (CTA)
membranes, similar to those used in the urine cell, are widely
used in reverse osmosis (RO) applications and inorganic
rejection data are available from suppliers and from published
technical articles. Ammonia is present in low or modest per-
55 centages in fresh urine. The normal range of urine ammonia
for healthy adults is 200-500 ppm. This is a product of urea
hydrolysis, a relatively slow process, and treatment within 1
hour of urine generation should help to keep concentrations of
ammonia low in the feed and in the product. Most ammonia
6o and nitrogen that is present will be removed from the feed by
an AC filter.
In future urine cell designs it may be desirable to enhance
the ammonia removal beyond the capabilities of the current
(above claimed) design. This wouldbe accomplished through
65 the addition of a 3rd treatment step located between the AC
and the FO membrane steps of the urine cell, and would
simply require a chemical addition during step 33 (FIG. 3:
US 7,655,145 B1
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Step 33). Ammonia that is not removed by theAC filter can be
further reduced by pH adjustment and/or by supplemental
absorption using diatomaceous Earth or an amine chemical
addition following AC treatment but prior to FO treatment.
Low pH (highly acidic) values ensure that ammonia in solu-
tion exists predominantly as the ammonium ion. Ammonium
ions can be removed by micro-porous membranes. Ammonia
can also be removed by diatomaceous Earth or amines. In
ether case the additional pH adjustment and/or chemical addi-
tion would be provided between to AC and FO treatments (at
step 33) and is claimed as a process improvement option to be
freely exercised (without farther patenting applications to the
primary invention) should it become desirable or necessary.
The urine cell may be usable more than once, until the
osmotic strength of salt in the bag approach the osmotic
strength of the sugar in the fortified drink. The urine cell is
relatively small and can be incorporated into a flight suit or a
space suit and thus become an integral part of a spaceworker's
apparel. If the urine cell is made part of a pressure suit the cell
may be useful during a specified 120-hour un-pressurized
emergency return to Earth capability in a CEV. During an
emergency, the urine cell can provide emergency urine col-
lection and drinking water supplies, as a redundant backup.
The urine cell uses no electrical power, has no complicated
mechanical parts to break or to require maintenance, is silent,
and has a shelf life in excess of one year. The cell includes a
flexible plastic pouch, surgical tubing, an AC filter, and a
water collection device.
The membrane may be hydrophilic, where the membrane
pore diameters are as large as, or slightly larger than the
minimum diameter required allow liquid phase water to flow,
but are smaller than required to pass most organic molecules.
Some relatively small organic, non-polar compounds will
pass through these pores. The preferred design utilizes hydro-
philic membranes, but hydrophobic membranes, in which
pore diameters are much smaller, can also be used when
desirable. Hydrophilic membranes are preferable for the cur-
rent design because they achieve reasonable flux or through-
put (water production rates), but future application may chose
to reduce flux rate for better rejection of urea, in which case
hydrophobic membranes would be used without further
modification to the concept design. Water transfer rates are
about 14 liters/hour/(meter)2 and 0.04 liters/hour/(meter)2 for
the hydrophilic and hydrophobic membranes, respectively.
The membrane surface area can be increased by using a
pleated membrane sheet or by using a plurality of helices to
increase the effective surface area of the membrane.
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What is claimed is:
1. A method for treatment of a liquid containing urea, the
method comprising:
receiving a liquid containing urea (urea containing liquid
5 or "UCL"), having a salt content of at least 5 gm/liter and
having a total organic content ("TOC") of at least 2500
mg/liter;
passing the UCL through an activated carbon filter to pro-
duce an intermediate liquid, in which at least 90 percent
10	 of organic molecules have been removed, within about
one hour after the UCL was generated;
providing a semipermeable membrane, having a first side
and a second side, and being selected to allow passage
therethrough of water in the intermediate liquid in a
15	 direction that tends to equalize osmotic potential of
water on the first and second sides of the membrane;
positioning the intermediate liquid in contact with at least
a portion of the membrane first side;
positioning a concentrated fortified drink, having a higher
20 liquid osmotic potential for water than a UCL osmotic
potential for water on the membrane first side, in contact
with at least a portion of the membrane second side; and
allowing a portion of the intermediate liquid to pass
through the membrane from the first side to the second
25 side to tend to reduce an imbalance of osmotic potential
of the liquids on the first and second sides of the mem-
brane, and to produce a processed liquid having a TOC
of no more than 25-50 mg/liter.
2. The method of claim 1, further comprising collecting at
30 least a portion of a mixture of said fortified drink and said
water that has passed through said membrane, on said mem-
brane second side.
3. The method of claim 1, further comprising maintaining
or increasing salinity of said UCL before passing said UCL
35 through said activated carbon filter, to promote additional
removal of organic molecules by said activated carbon filter.
4. The method of claim 1, further comprising providing a
hydrophilic membrane as said semipermeable membrane.
5. The method of claim 1, further comprising providing a
4o hydrophobic membrane as said semipermeable membrane.
6. The method of claim 1, further comprising adjusting pH
of said UCL after passing said UCL through said activated
carbon filter, to promote separation of a selected contaminant
from said by said membrane.
45	 7. The method of claim 1, further comprising removing at
least 95 percent of urea from said UCL.
8. The method of claim 5, further comprising removing at
least 99 percent of said urea from said UCL.
